title: Effect of α-thalassaemia on exercise-induced oxidative stress in sickle cell trait.
abstract: OBJECTIVE
  Alpha-thalassaemia is known to reduce intra-erythrocyte HbS (sickle haemoglobin) concentration in sickle cell trait (SCT) subjects. Because HbS was shown to increase oxidative stress, the purpose of this study was to assess the effects of the coexistence of α-thalassaemia and SCT on oxidative stress markers and nitric oxide (NO) metabolism after an acute physical exercise.
  
  
  METHODS
  Forty subjects (age: 23.5 ± 2.21 years), SCT carriers (HbAS) or healthy subjects (HbAA), with (-αT) or without (-NαT) an associated α-thalassaemia took part in the study. Plasma markers of oxidative stress [advanced oxidation protein products (AOPP), protein carbonyl, malondialdehyde (MDA) and nitrotyrosine], anti-oxidant defences and NO metabolism (NOx) were measured at rest (T(rest)), immediately following an incremental maximal exercise test (T(ex)) and during recovery (T(1h), T(2h) and T(24h)).
  
  
  RESULTS
  Malondialdehyde expressed as the percentage of changes from baseline was significantly higher in the HbAS-NαT compared with HbAS-αT during recovery (+36.3 ± 14.1% vs. -1.8 ± 13.2% at T(1h), P = 0.02; +36.6 ± 13.4% vs. -11.4 ± 12.5% at T(2h), P = 0.004 and +24.1 ± 12.3% vs. -14.4 ± 11.5% at T(24h), P = 0.02 in HbAS-NαT vs. HbAS-αT). Compared with HbAS-NαT, HbAS-αT had a higher NOx change from baseline at T(ex) (-23.4 ± 20.6% vs. +57.7 ± 19.3%, respectively; P = 0.005) and lower nitrotyrosine change from baseline at T(1h) (+7.2 ± 22.2% vs. +93.5%±29.3%, respectively; P = 0.04).
  
  
  CONCLUSIONS
  All these data suggest that the presence of α-thalassaemia may blunt the higher level of oxidative stress and the impaired bioavailability of NO observed in the SCT carriers.
authors.affiliation: Center of Research and Innovation on Sports (CRIS EA647), University Claude Bernard Lyon 1, University of Lyon, Lyon, France.
authors.forename: C
authors.initials: C
authors.lastname: Faёs
authors.forename: C
authors.initials: C
authors.lastname: Martin
authors.forename: E N
authors.initials: EN
authors.lastname: Chirico
authors.forename: L
authors.initials: L
authors.lastname: Féasson
authors.forename: S
authors.initials: S
authors.lastname: Oyonno-Enguelle
authors.forename: H
authors.initials: H
authors.lastname: Dubouchaud
authors.forename: A
authors.initials: A
authors.lastname: Francina
authors.forename: P
authors.initials: P
authors.lastname: Thiriet
authors.forename: V
authors.initials: V
authors.lastname: Pialoux
authors.forename: L
authors.initials: L
authors.lastname: Messonnier
mesh_terms: D000328:Adult; D000975:Antioxidants / Q000378:metabolism; D015415:Biomarkers; D015444:Exercise / Q000502:physiology*; D036681:Fluorescence Recovery After Photobleaching; D006801:Humans; D008297:Male; D009569:Nitric Oxide / Q000097:blood / Q000378:metabolism; D018384:Oxidative Stress / Q000502:physiology*; D012805:Sickle Cell Trait / Q000150:complications / Q000378:metabolism*; D014443:Tyrosine / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism; D055815:Young Adult; D017085:alpha-Thalassemia / Q000150:complications / Q000378:metabolism*
chemical_list: D000975:Antioxidants; D015415:Biomarkers; D009569:Nitric Oxide; C002744:3-nitrotyrosine; D014443:Tyrosine